<?xml version='1.0' encoding='us-ascii'?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">
<DOCID>54</DOCID>
<TEXT>
Exhibit . <EVENT class="COREFERENCE" eid="e0">Redactions</EVENT> with respect to certain portions hereof <EVENT class="COREFERENCE" eid="e1">denoted</EVENT> with "***" COLLABORATION AGREEMENT This Collaboration Agreement (the "Agreement") is <EVENT class="COREFERENCE" eid="e2">made</EVENT> as of April th, (the "Effective Date ") by and between Anixa Biosciences, Inc., a Delaware corporation, <EVENT class="COREFERENCE" eid="e3">located</EVENT> at Almaden Expressway, Suite , San Jose, CA , U.S.A. ("Anixa"), and OntoChem GmbH, a German limited liability company, <EVENT class="COREFERENCE" eid="e4">located</EVENT> at Blcherstr. , D- Halle (Saale), Germany ("OntoChem"). Anixa and OntoChem are <EVENT class="COREFERENCE" eid="e5">referred</EVENT> to herein individually as a "Party" and collectively as the "Parties." WHEREAS, the Parties <EVENT class="COREFERENCE" eid="e6">wish</EVENT> to <EVENT class="COREFERENCE" eid="e7">collaborate</EVENT> in the <EVENT class="COREFERENCE" eid="e8">discovery</EVENT> and <EVENT class="COREFERENCE" eid="e9">development</EVENT> of novel drug candidates for the <EVENT class="COREFERENCE" eid="e10">treatment</EVENT> of COVID- in accordance with the terms and conditions of this Agreement. NOW, THEREFORE, in consideration of the premises and the mutual promises set forth in this Agreement, and other good and valuable consideration, the <EVENT class="COREFERENCE" eid="e11">receipt</EVENT> and sufficiency of which are hereby <EVENT class="COREFERENCE" eid="e12">acknowledged</EVENT> , the Parties <EVENT class="COREFERENCE" eid="e13">agree</EVENT> as follows : . <EVENT class="COREFERENCE" eid="e14">Defined</EVENT> Terms. . "Affiliate" means, with respect to a Party, any entity directly or indirectly controlled by, controlling or under common control with such Party. For purposes of this definition, "control" means (a) ownership of fifty percent ( %) (or such lesser percentage which is the maximum allowed to be owned by a foreign entity or investor in a particular jurisdiction) or more of the outstanding voting stock or other ownership interest of an entity, or (b) possession of the power to (i) elect, appoint, direct or remove fifty percent ( %) or more of the members of the board of directors or other governing body of an entity or (ii) otherwise direct or cause the direction of the <EVENT class="COREFERENCE" eid="e15">management</EVENT> or policies of an entity by contract or otherwise. . "Hit Compound" means any chemical entity that is determined in performing the Research Plan to meet the Hit Criteria. . "Hit Criteria" means the criteria identified as "Hit Criteria" as set forth in the Research Plan. . "<EVENT class="COREFERENCE" eid="e16">Invention</EVENT> means any <EVENT class="COREFERENCE" eid="e17">invention</EVENT> know-how, data, <EVENT class="COREFERENCE" eid="e18">discovery</EVENT> or proprietary information, whether or not patentable, that is made or generated solely by the Representatives of Anixa or OntoChem or jointly by the Representatives of Anixa and OntoChem in performing the Research Plan, including all intellectual property rights in the foregoing. . "Representative" means, with respect to a Party, an officer, director, employee, agent or permitted subcontractor of such Party. . "Research Plan" means the research plan attached hereto as Exhibit A. . "SAR" means the relationship between the chemical or three-dimensional structure of a compound and its biological activity, and includes the <EVENT class="COREFERENCE" eid="e19">determination</EVENT> of the chemical groups responsible for evoking a target biological <EVENT class="COREFERENCE" eid="e20">effect</EVENT> . "Target" means: (a) any protease of any coronavirus, including Mpro; (b) the Nsp -pRB ribonuclease protein- protein <EVENT class="COREFERENCE" eid="e21">interaction</EVENT> (c) all mutants and variants of any molecule or component referenced in clauses (a) or (b); and (d) all truncated forms (including fragments) of any molecule or component referenced in clauses (a) or (b) or mutant or variant referenced in clause (c). . "Variant" means, with respect to any Hit Compound: (a) all compounds within the genus of compounds to which such Hit Compound would belong under United States patent laws as referenced in the Selection Notice (as defined below); and (b) any base form, metabolite, ester, salt form, racemate, stereoisomer, polymorph, hydrate, anhydride or solvate of such Hit Compound or any other compound described in clause (a) (in the case of this clause (b), without regard to whether such compound is referenced in the Selection Notice). . Research Program. . Performance. The Parties will diligently <EVENT class="COREFERENCE" eid="e22">perform</EVENT> their respective <EVENT class="COREFERENCE" eid="e23">activities</EVENT> set forth in the Research Plan (such <EVENT class="COREFERENCE" eid="e24">activities</EVENT> collectively, the "Research <EVENT class="COREFERENCE" eid="e25">Program</EVENT> ) in accordance with the timelines set forth therein, with the objective of <EVENT class="COREFERENCE" eid="e26">identifying</EVENT> Hit Compounds and Lead Scaffolds that <EVENT class="COREFERENCE" eid="e27">modulate</EVENT> the applicable Target. Without <EVENT class="COREFERENCE" eid="e28">limiting</EVENT> the foregoing, OntoChem will (a) <EVENT class="COREFERENCE" eid="e29">provide</EVENT> all deliverables set forth in the Research Plan (each, a "Deliverable") and (b) <EVENT class="COREFERENCE" eid="e30">obtain</EVENT> any <EVENT class="COREFERENCE" eid="e31">authorizations</EVENT> <EVENT class="COREFERENCE" eid="e32">approvals</EVENT> and licenses <EVENT class="COREFERENCE" eid="e33">required</EVENT> for <EVENT class="COREFERENCE" eid="e34">performance</EVENT> of the Research Plan. If any terms set forth in the Research Plan conflict with the terms set forth in this Agreement, the terms of this Agreement will <EVENT class="COREFERENCE" eid="e35">control</EVENT> unless expressly <EVENT class="COREFERENCE" eid="e36">indicated</EVENT> to the contrary in the Research Plan. The Research Plan may not be <EVENT class="COREFERENCE" eid="e37">amended</EVENT> without the prior <EVENT class="COREFERENCE" eid="e38">written</EVENT> consent of both Parties. If, from time to time, the Parties <EVENT class="COREFERENCE" eid="e39">desire</EVENT> to <EVENT class="COREFERENCE" eid="e40">expand</EVENT> the scope of the Research Program, then they will <EVENT class="COREFERENCE" eid="e41">negotiate</EVENT> in good faith a potential <EVENT class="COREFERENCE" eid="e42">amendment</EVENT> of the Research Plan in regard to such <EVENT class="COREFERENCE" eid="e43">expanded</EVENT> scope, on commercially reasonable terms, but neither Party will be <EVENT class="COREFERENCE" eid="e44">obligated</EVENT> to <EVENT class="COREFERENCE" eid="e45">enter</EVENT> into any such <EVENT class="COREFERENCE" eid="e46">amendment</EVENT> . Weekly Updates. OntoChem will <EVENT class="COREFERENCE" eid="e47">provide</EVENT> Anixa with weekly (or more frequently as <EVENT class="COREFERENCE" eid="e48">requested</EVENT> ) <EVENT class="COREFERENCE" eid="e49">updates</EVENT> <EVENT class="COREFERENCE" eid="e50">updates</EVENT> <EVENT class="COREFERENCE" eid="e51">regarding</EVENT> its <EVENT class="COREFERENCE" eid="e52">progress</EVENT> under the Research <EVENT class="COREFERENCE" eid="e53">Program</EVENT> via teleconference, videoconference or e-mail, and the Parties will <EVENT class="COREFERENCE" eid="e54">make</EVENT> appropriate personnel available in a timely manner to <EVENT class="COREFERENCE" eid="e55">discuss</EVENT> and <EVENT class="COREFERENCE" eid="e56">provide</EVENT> <EVENT class="COREFERENCE" eid="e57">feedback</EVENT> in regard to such <EVENT class="COREFERENCE" eid="e58">updates</EVENT> . Delivery of Data. In conjunction with each weekly update <EVENT class="COREFERENCE" eid="e59">described</EVENT> in Section . , OntoChem will <EVENT class="COREFERENCE" eid="e60">deliver</EVENT> to Anixa all data <EVENT class="COREFERENCE" eid="e61">generated</EVENT> under the Research Plan since the <EVENT class="COREFERENCE" eid="e62">preceding</EVENT> <EVENT class="COREFERENCE" eid="e63">update</EVENT> In addition, Anixa will have the right to reasonably <EVENT class="COREFERENCE" eid="e64">request</EVENT> additional information <EVENT class="COREFERENCE" eid="e65">relating</EVENT> to such data, and OntoChem will <EVENT class="COREFERENCE" eid="e66">respond</EVENT> to such <EVENT class="COREFERENCE" eid="e67">requests</EVENT> promptly with any such additional information in its possession or control, <EVENT class="COREFERENCE" eid="e68">provided</EVENT> that, for clarity, OntoChem will not be <EVENT class="COREFERENCE" eid="e69">required</EVENT> to <EVENT class="COREFERENCE" eid="e70">perform</EVENT> any new or additional <EVENT class="COREFERENCE" eid="e71">research</EVENT> in order to <EVENT class="COREFERENCE" eid="e72">generate</EVENT> any such additional information. . Selection of Lead Scaffolds. Within one year <EVENT class="COREFERENCE" eid="e73">following</EVENT> <EVENT class="COREFERENCE" eid="e74">completion</EVENT> of all <EVENT class="COREFERENCE" eid="e75">activities</EVENT> under the Research Plan (the "Selection Deadline"), Anixa, in good faith <EVENT class="COREFERENCE" eid="e76">consultation</EVENT> with OntoChem, will have the right to <EVENT class="COREFERENCE" eid="e77">select</EVENT> up to two hundred ( ) Hit Compounds (each, a "Selected Hit Compound"), by <EVENT class="COREFERENCE" eid="e78">providing</EVENT> OntoChem with written notice of such Selected Hit Compound(s) (the "Selection Notice"), and each <EVENT class="COREFERENCE" eid="e79">Selected</EVENT> Hit Compound, along with all Variants of such Selected Hit Compound <EVENT class="COREFERENCE" eid="e80">referenced</EVENT> in the Selection Notice, is hereby <EVENT class="COREFERENCE" eid="e81">designated</EVENT> as a "Lead Scaffold" under this Agreement. <EVENT class="COREFERENCE" eid="e82">Commencing</EVENT> upon <EVENT class="COREFERENCE" eid="e83">selection</EVENT> of a Selected Hit Compound, Anixa (itself and through its Affiliates and designees) will have sole authority over and control of the further <EVENT class="COREFERENCE" eid="e84">development</EVENT> <EVENT class="COREFERENCE" eid="e85">manufacture</EVENT> and <EVENT class="COREFERENCE" eid="e86">commercialization</EVENT> of the corresponding Lead Scaffold and any product candidate or product <EVENT class="COREFERENCE" eid="e87">incorporating</EVENT> a compound from such Lead Scaffold. <EVENT class="COREFERENCE" eid="e88">Following</EVENT> the Selection Deadline, Anixa will have no further rights with respect to any Hit Compound that is not a Selected Hit Compound or <EVENT class="COREFERENCE" eid="e89">included</EVENT> within a Lead Scaffold (each, a "Rejected Hit Compound"), <EVENT class="COREFERENCE" eid="e90">provided</EVENT> that, during the period of two ( ) years following the Selection Deadline, neither OntoChem nor any of its Affiliates will <EVENT class="COREFERENCE" eid="e91">use</EVENT> or <EVENT class="COREFERENCE" eid="e92">disclose</EVENT> to any third party any Rejected Hit Compound or any Variant thereof, <EVENT class="COREFERENCE" eid="e93">including</EVENT> the identity, structure or SAR information of any such compound, for application as anti-viral agents or protease inhibitors, for purposes of <EVENT class="COREFERENCE" eid="e94">modulating</EVENT> any Target or for <EVENT class="COREFERENCE" eid="e95">treatment</EVENT> of virus- <EVENT class="COREFERENCE" eid="e96">related</EVENT> conditions. In case OntoChem <EVENT class="COREFERENCE" eid="e97">finds</EVENT> a novel and unexpected antiviral <EVENT class="COREFERENCE" eid="e98">use</EVENT> of those <EVENT class="COREFERENCE" eid="e99">Rejected</EVENT> <EVENT class="COREFERENCE" eid="e100">Hit</EVENT> Compounds during this -years period , it will <EVENT class="COREFERENCE" eid="e101">notify</EVENT> Anixa about these <EVENT class="COREFERENCE" eid="e102">findings</EVENT> and Anixa has the right of first <EVENT class="COREFERENCE" eid="e103">negotiation</EVENT> during a period of months after this <EVENT class="COREFERENCE" eid="e104">notification</EVENT> If Anixa <EVENT class="COREFERENCE" eid="e105">decides</EVENT> to not <EVENT class="COREFERENCE" eid="e106">license</EVENT> those <EVENT class="COREFERENCE" eid="e107">uses</EVENT> or compounds for this novel antiviral use, OntoChem is free to <EVENT class="COREFERENCE" eid="e108">develop</EVENT> those molecules further as its own intellectual property without any further restrictions. . Subcontractors. OntoChem may <EVENT class="COREFERENCE" eid="e109">engage</EVENT> one or more subcontractors to <EVENT class="COREFERENCE" eid="e110">perform</EVENT> its <EVENT class="COREFERENCE" eid="e111">activities</EVENT> under the Research Plan with the prior <EVENT class="COREFERENCE" eid="e112">written</EVENT> approval of Anixa and <EVENT class="COREFERENCE" eid="e113">provided</EVENT> that, with respect to any such subcontractor, OntoChem will (a) be responsible and liable for the <EVENT class="COREFERENCE" eid="e114">performance</EVENT> of such subcontractor and (b) <EVENT class="COREFERENCE" eid="e115">enter</EVENT> into a <EVENT class="COREFERENCE" eid="e116">written</EVENT> agreement (i) consistent with terms and conditions of this Agreement, <EVENT class="COREFERENCE" eid="e117">including</EVENT> with respect to confidentiality and intellectual property, and (ii) <EVENT class="COREFERENCE" eid="e118">prohibiting</EVENT> such subcontractor from further subcontracting. For clarity, vendors where commercial building blocks or compounds will be <EVENT class="COREFERENCE" eid="e119">purchased</EVENT> are nor <EVENT class="COREFERENCE" eid="e120">regarded</EVENT> as subcontractors. . Target Exclusivity. During the term of this Agreement, except in the <EVENT class="COREFERENCE" eid="e121">performance</EVENT> of its obligations or <EVENT class="COREFERENCE" eid="e122">exercise</EVENT> of its rights under this Agreement, neither OntoChem nor any of its Affiliates will <EVENT class="COREFERENCE" eid="e123">discover</EVENT> , <EVENT class="COREFERENCE" eid="e124">research</EVENT> , <EVENT class="COREFERENCE" eid="e125">develop</EVENT> , <EVENT class="COREFERENCE" eid="e126">manufacture</EVENT> or <EVENT class="COREFERENCE" eid="e127">commercialize</EVENT> any compound or product <EVENT class="COREFERENCE" eid="e128">directed</EVENT> to any Target, either independently or for or in collaboration with a third party ( <EVENT class="COREFERENCE" eid="e129">including</EVENT> the grant of a license to any third party), or have any of the foregoing <EVENT class="COREFERENCE" eid="e130">activities</EVENT> <EVENT class="COREFERENCE" eid="e131">performed</EVENT> on behalf of OntoChem or any of its Affiliates by a third party. For clarity, the foregoing <EVENT class="COREFERENCE" eid="e132">includes</EVENT> the <EVENT class="COREFERENCE" eid="e133">screening</EVENT> ( <EVENT class="COREFERENCE" eid="e134">including</EVENT> via computational methods) of any compound library or virtual compound library against any Target. . Records. Each Party will <EVENT class="COREFERENCE" eid="e135">maintain</EVENT> complete and accurate records of all <EVENT class="COREFERENCE" eid="e136">activities</EVENT> <EVENT class="COREFERENCE" eid="e137">performed</EVENT> by or on behalf of such Party under the Research Program and all <EVENT class="COREFERENCE" eid="e138">Inventions</EVENT> <EVENT class="COREFERENCE" eid="e139">made</EVENT> or <EVENT class="COREFERENCE" eid="e140">generated</EVENT> by or on behalf of such Party in the <EVENT class="COREFERENCE" eid="e141">performance</EVENT> of the Research Program. Such records will be in sufficient detail and in good scientific manner appropriate for patent and regulatory purposes. Each Party will <EVENT class="COREFERENCE" eid="e142">provide</EVENT> the other Party with the right to <EVENT class="COREFERENCE" eid="e143">inspect</EVENT> such records, and upon <EVENT class="COREFERENCE" eid="e144">request</EVENT> will <EVENT class="COREFERENCE" eid="e145">provide</EVENT> copies of all such records, to the extent reasonably <EVENT class="COREFERENCE" eid="e146">required</EVENT> for the <EVENT class="COREFERENCE" eid="e147">exercise</EVENT> or <EVENT class="COREFERENCE" eid="e148">performance</EVENT> of such other Party's rights or obligations under this Agreement, <EVENT class="COREFERENCE" eid="e149">provided</EVENT> that any information <EVENT class="COREFERENCE" eid="e150">disclosed</EVENT> under this Section . will be subject to the terms and conditions of Section . Each Party will <EVENT class="COREFERENCE" eid="e151">retain</EVENT> such records for at least three ( ) years following <EVENT class="COREFERENCE" eid="e152">expiration</EVENT> or <EVENT class="COREFERENCE" eid="e153">termination</EVENT> of this Agreement or such longer period as may be <EVENT class="COREFERENCE" eid="e154">required</EVENT> by applicable law or regulation. . Debarment. Each Party hereby <EVENT class="COREFERENCE" eid="e155">represents</EVENT> and warrants to the other Party that neither it nor any of its Affiliates or personnel has been <EVENT class="COREFERENCE" eid="e156">debarred</EVENT> under any health care laws or regulations and that, to its knowledge, no <EVENT class="COREFERENCE" eid="e157">investigations</EVENT> <EVENT class="COREFERENCE" eid="e158">investigations</EVENT> <EVENT class="COREFERENCE" eid="e159">claims</EVENT> <EVENT class="COREFERENCE" eid="e160">claims</EVENT> or <EVENT class="COREFERENCE" eid="e161">proceedings</EVENT> <EVENT class="COREFERENCE" eid="e162">proceedings</EVENT> with respect to <EVENT class="COREFERENCE" eid="e163">debarment</EVENT> are <EVENT class="COREFERENCE" eid="e164">pending</EVENT> or <EVENT class="COREFERENCE" eid="e165">threatened</EVENT> against such Party or any of its Affiliates or personnel. Neither Party nor any of its Affiliates will <EVENT class="COREFERENCE" eid="e166">use</EVENT> in any capacity, in connection with the Research Program, any person or entity who has been <EVENT class="COREFERENCE" eid="e167">debarred</EVENT> . Each Party <EVENT class="COREFERENCE" eid="e168">agrees</EVENT> and <EVENT class="COREFERENCE" eid="e169">undertakes</EVENT> to promptly <EVENT class="COREFERENCE" eid="e170">notify</EVENT> the other Party if such Party or any of its Affiliates or personnel <EVENT class="COREFERENCE" eid="e171">becomes</EVENT> <EVENT class="COREFERENCE" eid="e172">debarred</EVENT> or <EVENT class="COREFERENCE" eid="e173">proceedings</EVENT> have been <EVENT class="COREFERENCE" eid="e174">initiated</EVENT> against any of them with respect to <EVENT class="COREFERENCE" eid="e175">debarment</EVENT> whether such <EVENT class="COREFERENCE" eid="e176">debarment</EVENT> or <EVENT class="COREFERENCE" eid="e177">initiation</EVENT> of <EVENT class="COREFERENCE" eid="e178">proceedings</EVENT> <EVENT class="COREFERENCE" eid="e179">occurs</EVENT> during or after the term of this Agreement. . Financial Terms. . Research Program Payments. In consideration for OntoChem's <EVENT class="COREFERENCE" eid="e180">performance</EVENT> of its <EVENT class="COREFERENCE" eid="e181">activities</EVENT> under the Research Plan, Anixa will: (a) <EVENT class="COREFERENCE" eid="e182">pay</EVENT> OntoChem , Euros in six ( ) equal installments as follows : (i) , Euros within five ( ) days after the Effective Date ; and (ii) five ( ) installments in the amount of , Euros on each one-month anniversary of the Effective Date , except that the last such <EVENT class="COREFERENCE" eid="e183">payment</EVENT> will be due within thirty ( ) days after <EVENT class="COREFERENCE" eid="e184">completion</EVENT> of all <EVENT class="COREFERENCE" eid="e185">activities</EVENT> under the Research Plan; and (b) <EVENT class="COREFERENCE" eid="e186">reimburse</EVENT> OntoChem for its out-of-pocket expenses <EVENT class="COREFERENCE" eid="e187">incurred</EVENT> in <EVENT class="COREFERENCE" eid="e188">performing</EVENT> the Research Plan on a pass- through basis without mark-up, within thirty ( ) days after <EVENT class="COREFERENCE" eid="e189">delivery</EVENT> of an invoice therefore ( <EVENT class="COREFERENCE" eid="e190">including</EVENT> reasonable <EVENT class="COREFERENCE" eid="e191">supporting</EVENT> documentation), <EVENT class="COREFERENCE" eid="e192">provided</EVENT> that Anixa has <EVENT class="COREFERENCE" eid="e193">approved</EVENT> such expenses in advance and in writing ( including in regard to the <EVENT class="COREFERENCE" eid="e194">selection</EVENT> of specific Hit Compounds to be <EVENT class="COREFERENCE" eid="e195">synthesized</EVENT> and <EVENT class="COREFERENCE" eid="e196">analyzed</EVENT> in biological assays). It is <EVENT class="COREFERENCE" eid="e197">estimated</EVENT> that OntoChem's out-of-pocket expenses under the Research Plan will <EVENT class="COREFERENCE" eid="e198">include</EVENT> , Euros payable to Tube Pharmaceuticals GmbH as a subcontractor of OntoChem, subject to Section . . (c) High-throughput screening compounds OntoChem will forward a commercial <EVENT class="COREFERENCE" eid="e199">proposal</EVENT> to <EVENT class="COREFERENCE" eid="e200">acquire</EVENT> these compounds at the sole discretion of Anixa. Both parties will <EVENT class="COREFERENCE" eid="e201">agree</EVENT> on payment conditions. (d) Extra custom synthesis OntoChem will forward a commercial <EVENT class="COREFERENCE" eid="e202">proposal</EVENT> to have <EVENT class="COREFERENCE" eid="e203">synthesized</EVENT> these compounds at the sole discretion of Anixa. Both parties will <EVENT class="COREFERENCE" eid="e204">agree</EVENT> on payment conditions. (e) Biological testing OntoChem will forward a commercial <EVENT class="COREFERENCE" eid="e205">proposal</EVENT> to have biologically <EVENT class="COREFERENCE" eid="e206">test</EVENT> these compounds at the sole discretion of Anixa. Both parties will <EVENT class="COREFERENCE" eid="e207">agree</EVENT> on payment conditions. . Lead Scaffold Payments. For each Lead Scaffold <EVENT class="COREFERENCE" eid="e208">selected</EVENT> by Anixa, Anixa will <EVENT class="COREFERENCE" eid="e209">pay</EVENT> OntoChem an annual fee of , U.S. Dollars, payable within thirty ( ) days following each anniversary of the date of the Selection Notice, until five ( ) years after the first commercial <EVENT class="COREFERENCE" eid="e210">sale</EVENT> of the first product <EVENT class="COREFERENCE" eid="e211">incorporating</EVENT> a compound from such Lead Scaffold, subject to Section . with respect to any Terminated Scaffold (as <EVENT class="COREFERENCE" eid="e212">defined</EVENT> below). . Milestone Payment. Anixa will <EVENT class="COREFERENCE" eid="e213">pay</EVENT> OntoChem a one-time milestone <EVENT class="COREFERENCE" eid="e214">payment</EVENT> of , U.S. Dollars within thirty ( ) days following the <EVENT class="COREFERENCE" eid="e215">dosing</EVENT> of the first patient in the first human clinical trial for the first product <EVENT class="COREFERENCE" eid="e216">incorporating</EVENT> a compound from a Lead Scaffold. . Payment Terms. <EVENT class="COREFERENCE" eid="e217">Payments</EVENT> to OntoChem will be <EVENT class="COREFERENCE" eid="e218">made</EVENT> by check or by wire transfer of immediately available funds to such bank account as <EVENT class="COREFERENCE" eid="e219">designated</EVENT> in writing by OntoChem from time to time. Taxes (and any penalties and interest thereon) <EVENT class="COREFERENCE" eid="e220">imposed</EVENT> on any <EVENT class="COREFERENCE" eid="e221">payment</EVENT> <EVENT class="COREFERENCE" eid="e222">made</EVENT> by Anixa to OntoChem will be the responsibility of OntoChem. The fees for the respective bank <EVENT class="COREFERENCE" eid="e223">transfers</EVENT> will be <EVENT class="COREFERENCE" eid="e224">borne</EVENT> by Anixa. . Financial Records. OntoChem will <EVENT class="COREFERENCE" eid="e225">maintain</EVENT> complete and accurate books and accounting records <EVENT class="COREFERENCE" eid="e226">related</EVENT> to all out-of-pocket expenses <EVENT class="COREFERENCE" eid="e227">incurred</EVENT> in <EVENT class="COREFERENCE" eid="e228">performing</EVENT> the Research Plan. These records will be available for <EVENT class="COREFERENCE" eid="e229">inspection</EVENT> during regular business hours upon reasonable <EVENT class="COREFERENCE" eid="e230">notice</EVENT> by Anixa, or its duly <EVENT class="COREFERENCE" eid="e231">authorized</EVENT> representative, at Anixa's expense, for three ( ) years following the end of the calendar year in which such expenses are <EVENT class="COREFERENCE" eid="e232">invoiced</EVENT> . If it is <EVENT class="COREFERENCE" eid="e233">determined</EVENT> that Anixa has <EVENT class="COREFERENCE" eid="e234">overpaid</EVENT> for any expenses <EVENT class="COREFERENCE" eid="e235">passed</EVENT> through by OntoChem under this Agreement, OntoChem will promptly <EVENT class="COREFERENCE" eid="e236">reimburse</EVENT> Anixa for the amount of such <EVENT class="COREFERENCE" eid="e237">overpayment</EVENT> and, if such <EVENT class="COREFERENCE" eid="e238">overpayment</EVENT> <EVENT class="COREFERENCE" eid="e239">represents</EVENT> more than five percent ( %) of the corresponding amount due, OntoChem will <EVENT class="COREFERENCE" eid="e240">pay</EVENT> Anixa's reasonable fees and expenses <EVENT class="COREFERENCE" eid="e241">incurred</EVENT> in connection with such <EVENT class="COREFERENCE" eid="e242">inspection</EVENT> . Term and Termination. . Term . Unless earlier <EVENT class="COREFERENCE" eid="e243">terminated</EVENT> in accordance with Section . or . , this Agreement will be in effect from the Effective Date until <EVENT class="COREFERENCE" eid="e244">completion</EVENT> of the Research Program. . Termination by Anixa. This Agreement may be <EVENT class="COREFERENCE" eid="e245">terminated</EVENT> by Anixa, without cause, upon at least thirty ( ) days <EVENT class="COREFERENCE" eid="e246">written</EVENT> notice to OntoChem. . Termination of Lead Scaffolds.
</TEXT>
<MAKEINSTANCE aspect="NONE" eiid="ei13544" eventID="e0" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13545" eventID="e1" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13546" eventID="e2" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13547" eventID="e3" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13548" eventID="e4" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13549" eventID="e5" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13550" eventID="e6" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13551" eventID="e7" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13552" eventID="e8" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13553" eventID="e9" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13554" eventID="e10" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13555" eventID="e11" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13556" eventID="e12" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13557" eventID="e13" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13558" eventID="e14" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13559" eventID="e15" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13560" eventID="e16" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13561" eventID="e17" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13562" eventID="e18" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13563" eventID="e19" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13564" eventID="e20" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13565" eventID="e21" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13566" eventID="e22" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13567" eventID="e23" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13568" eventID="e24" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13569" eventID="e25" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13570" eventID="e26" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13571" eventID="e27" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13572" eventID="e28" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13573" eventID="e29" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13574" eventID="e30" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13575" eventID="e31" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13576" eventID="e32" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13577" eventID="e33" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13578" eventID="e34" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13579" eventID="e35" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13580" eventID="e36" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13581" eventID="e37" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13582" eventID="e38" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13583" eventID="e39" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13584" eventID="e40" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13585" eventID="e41" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13586" eventID="e42" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13587" eventID="e43" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13588" eventID="e44" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13589" eventID="e45" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13590" eventID="e46" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13591" eventID="e47" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13592" eventID="e48" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13593" eventID="e49" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13594" eventID="e50" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13595" eventID="e51" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13596" eventID="e52" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13597" eventID="e53" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13598" eventID="e54" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13599" eventID="e55" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13600" eventID="e56" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13601" eventID="e57" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13602" eventID="e58" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13603" eventID="e59" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13604" eventID="e60" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13605" eventID="e61" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13606" eventID="e62" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13607" eventID="e63" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13608" eventID="e64" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13609" eventID="e65" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13610" eventID="e66" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13611" eventID="e67" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13612" eventID="e68" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13613" eventID="e69" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13614" eventID="e70" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13615" eventID="e71" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13616" eventID="e72" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13617" eventID="e73" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13618" eventID="e74" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13619" eventID="e75" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13620" eventID="e76" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13621" eventID="e77" polarity="POS" pos="ADJECTIVE" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13622" eventID="e78" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13623" eventID="e79" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13624" eventID="e80" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13625" eventID="e81" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13626" eventID="e82" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13627" eventID="e83" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13628" eventID="e84" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13629" eventID="e85" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13630" eventID="e86" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13631" eventID="e87" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13632" eventID="e88" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13633" eventID="e89" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13634" eventID="e90" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13635" eventID="e91" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13636" eventID="e92" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13637" eventID="e93" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13638" eventID="e94" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13639" eventID="e95" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13640" eventID="e96" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13641" eventID="e97" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13642" eventID="e98" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13643" eventID="e99" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13644" eventID="e100" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13645" eventID="e101" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13646" eventID="e102" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13647" eventID="e103" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13648" eventID="e104" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13649" eventID="e105" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13650" eventID="e106" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13651" eventID="e107" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13652" eventID="e108" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13653" eventID="e109" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13654" eventID="e110" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13655" eventID="e111" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13656" eventID="e112" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13657" eventID="e113" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13658" eventID="e114" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13659" eventID="e115" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13660" eventID="e116" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13661" eventID="e117" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13662" eventID="e118" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13663" eventID="e119" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13664" eventID="e120" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13665" eventID="e121" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13666" eventID="e122" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13667" eventID="e123" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13668" eventID="e124" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13669" eventID="e125" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13670" eventID="e126" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13671" eventID="e127" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13672" eventID="e128" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13673" eventID="e129" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13674" eventID="e130" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13675" eventID="e131" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13676" eventID="e132" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13677" eventID="e133" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13678" eventID="e134" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13679" eventID="e135" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13680" eventID="e136" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13681" eventID="e137" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13682" eventID="e138" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13683" eventID="e139" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13684" eventID="e140" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13685" eventID="e141" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13686" eventID="e142" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13687" eventID="e143" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13688" eventID="e144" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13689" eventID="e145" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13690" eventID="e146" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13691" eventID="e147" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13692" eventID="e148" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13693" eventID="e149" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13694" eventID="e150" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13695" eventID="e151" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13696" eventID="e152" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13697" eventID="e153" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13698" eventID="e154" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13699" eventID="e155" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13700" eventID="e156" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13701" eventID="e157" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13702" eventID="e158" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13703" eventID="e159" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13704" eventID="e160" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13705" eventID="e161" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13706" eventID="e162" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13707" eventID="e163" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13708" eventID="e164" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13709" eventID="e165" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13710" eventID="e166" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13711" eventID="e167" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13712" eventID="e168" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13713" eventID="e169" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13714" eventID="e170" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13715" eventID="e171" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13716" eventID="e172" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13717" eventID="e173" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13718" eventID="e174" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13719" eventID="e175" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13720" eventID="e176" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13721" eventID="e177" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13722" eventID="e178" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13723" eventID="e179" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13724" eventID="e180" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13725" eventID="e181" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13726" eventID="e182" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13727" eventID="e183" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13728" eventID="e184" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13729" eventID="e185" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13730" eventID="e186" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13731" eventID="e187" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13732" eventID="e188" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13733" eventID="e189" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13734" eventID="e190" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13735" eventID="e191" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13736" eventID="e192" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13737" eventID="e193" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13738" eventID="e194" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13739" eventID="e195" polarity="POS" pos="ADJECTIVE" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13740" eventID="e196" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13741" eventID="e197" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13742" eventID="e198" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13743" eventID="e199" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13744" eventID="e200" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13745" eventID="e201" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13746" eventID="e202" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13747" eventID="e203" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13748" eventID="e204" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13749" eventID="e205" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13750" eventID="e206" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13751" eventID="e207" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13752" eventID="e208" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13753" eventID="e209" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13754" eventID="e210" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13755" eventID="e211" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13756" eventID="e212" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13757" eventID="e213" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13758" eventID="e214" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13759" eventID="e215" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13760" eventID="e216" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13761" eventID="e217" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13762" eventID="e218" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13763" eventID="e219" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13764" eventID="e220" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13765" eventID="e221" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13766" eventID="e222" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13767" eventID="e223" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13768" eventID="e224" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13769" eventID="e225" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13770" eventID="e226" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13771" eventID="e227" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13772" eventID="e228" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13773" eventID="e229" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13774" eventID="e230" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13775" eventID="e231" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13776" eventID="e232" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13777" eventID="e233" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13778" eventID="e234" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13779" eventID="e235" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13780" eventID="e236" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13781" eventID="e237" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13782" eventID="e238" polarity="POS" pos="ADJECTIVE" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13783" eventID="e239" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13784" eventID="e240" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13785" eventID="e241" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13786" eventID="e242" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13787" eventID="e243" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13788" eventID="e244" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13789" eventID="e245" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei13790" eventID="e246" polarity="POS" pos="VERB" tense="NONE" />
</TimeML>